ICU Medical (NASDAQ:ICUI) and Otsuka Pharmaceutical Factory, a unit of Japan’s Otsuka, are launching a joint venture focused ...

Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along ...

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

NINER Pharmaceutical, a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American markets to address critical shortages of IV fluids. Responding to ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

Baxter International restarted its highest-throughput intravenous solutions manufacturing line at its hurricane-hit North Cove facility in North Carolina, the company announced Thursday.

When Hurricane Helene hit North Carolina last month, killing over 100 people and unleashing $53 billion worth of damage in ...

Like hospitals around the country, North Country Hospital is navigating the shortage of IV solution supplies, caused by the ...

IV fluid-maker Baxter Inc, which runs the Marion plant inundated by Helene, said Thursday that the restarted production line ...